Impact of metabolic syndrome on neuroinflammation and the bloodbrain barrier
We verified the impact of ACTL6A on GSH synthesis and confirmed that ACTL6A KD led to reduced expression of certain genes (GCLC, GPX2, GPX4, SLC7A11, SLC1A5, GSS, GLS, etc.) involved in the GSH synthesis pathway (Supplementary Fig
Our Peptide Therapy Program is designed for individuals looking to enhance recovery, improve metabolic health, and support overall vitality through scientifically backed peptide treatments
BPC-157 is a synthetic 15-amino acid peptide: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
22 The relationship between NO and phenomena related to the spinal transmission of nociceptive inputs has been generally studied using the effects of NOS inhibitors (NOSIs) on nociception-related electrophysiological responses of dorsal horn cells after formalin